1. Home
  2. CTKB vs MEGI Comparison

CTKB vs MEGI Comparison

Compare CTKB & MEGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.84

Market Cap

433.8M

Sector

Health Care

ML Signal

HOLD

Logo MainStay CBRE Global Infrastructure Megatrends Term Fund

MEGI

MainStay CBRE Global Infrastructure Megatrends Term Fund

HOLD

Current Price

$13.63

Market Cap

720.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTKB
MEGI
Founded
1990
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
433.8M
720.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CTKB
MEGI
Price
$4.84
$13.63
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$5.88
N/A
AVG Volume (30 Days)
1.4M
178.0K
Earning Date
11-05-2025
01-01-0001
Dividend Yield
N/A
11.40%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$196,828,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.37
$10.63
52 Week High
$7.30
$14.89

Technical Indicators

Market Signals
Indicator
CTKB
MEGI
Relative Strength Index (RSI) 49.85 40.31
Support Level $4.56 $13.43
Resistance Level $4.95 $13.74
Average True Range (ATR) 0.24 0.18
MACD -0.07 -0.00
Stochastic Oscillator 38.83 23.97

Price Performance

Historical Comparison
CTKB
MEGI

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About MEGI MainStay CBRE Global Infrastructure Megatrends Term Fund

NYLI CBRE Global Infrastructure Megatrends Term Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek a high level of total return with an emphasis on current income. It is focused on the investment megatrends of decarbonization, digital transformation and asset modernization, which are reshaping the demand for infrastructure assets and driving income and growth potential.

Share on Social Networks: